Management of Cardiorenal Syndrome

Introduction to Management

The American College of Cardiology recommends prioritizing cautious intravenous loop diuretic therapy to relieve congestion while avoiding ACE inhibitors and beta-blockers in patients with cardiorenal syndrome, systolic blood pressure of 85 mmHg, and creatinine of 170 µmol/L who refuse ICU care, and consider low-dose inotropic support if signs of tissue hypoperfusion develop 1

The American College of Cardiology suggests rapidly assessing signs of tissue hypoperfusion, including altered mental status, cool extremities, decreased urine output, and elevated lactate, as well as volume status, to determine the primary driver of congestion 2, 1
The European Heart Journal recommends continuous monitoring of heart rate, rhythm, blood pressure, and oxygen saturation for at least the first 24 hours, as well as hourly urine output measurement to assess diuretic response 3, 2

The American College of Cardiology recommends starting with intravenous furosemide at a dose equal to or exceeding the chronic oral daily dose, or beginning with 40-80 mg IV if diuretic-naïve, and monitoring urine output hourly 2, 1
The European Heart Journal suggests that given the elevated creatinine, higher doses of furosemide will likely be required, and considers starting at the upper end of the dosing range 3

The European Heart Journal recommends low-dose dopamine (2.5 μg/kg/min IV) to enhance renal perfusion when signs of renal hypoperfusion exist, though higher doses are not recommended for diuresis enhancement 3, 1
The American College of Cardiology suggests dobutamine (starting at 2.5 μg/kg/min, titrated up to 10 μg/kg/min) if pulmonary congestion dominates the clinical picture with evidence of low cardiac output 1

The American College of Cardiology recommends avoiding ACE inhibitors, ARBs, or beta-blockers in patients with systolic blood pressure less than 80 mmHg or signs of peripheral hypoperfusion 5, 1
The European Journal of Heart Failure suggests avoiding NSAIDs, which reduce diuretic efficacy and worsen renal function 6, 1

The Journal of the American College of Cardiology recommends considering venovenous isolated ultrafiltration when doubling diuretic doses and adding a second diuretic fail to produce adequate diuresis while the patient remains in pulmonary edema 4, 3

The American College of Cardiology recommends initiating a goals of care discussion addressing prognosis, treatment limitations, and symptom management priorities in patients with advanced disease state 1
The American College of Cardiology suggests considering palliative care consultation for symptom management and goals of care alignment in patients with advanced heart failure 1